// App-Quantinova.ai

: Risk of death and cardiovascular events among patients presenting with acute coronary syndrome: the evolving role of cystatin C, NGAL and galectin-3 as prognostic biomarkers

Researchers

Presenter

  • D.N. Nanchen

Principal Investigators

  • C.M. Matter

  • T.F. Luescher

Medical Centers

  • University Hospital Centre Vaudois (CHUV) - Lausanne - Switzerland

  • University Hospital Zurich, Clinic of Oncology, Zurich, Switzerland

Locations

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • Cystatin C

  • Galectin-3

  • Lipocalin 2

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved